Characterizing spatial immune architecture in metastatic melanoma using high-dimensional multiplex imaging.
Saved in:
| Title: | Characterizing spatial immune architecture in metastatic melanoma using high-dimensional multiplex imaging. |
|---|---|
| Authors: | Eliason J; Department of Computational Medicine and Bioinformatics, University of Michigan, Ann Arbor, MI, United States., Krishnan S; Department of Computational Medicine and Bioinformatics, University of Michigan, Ann Arbor, MI, United States., Fukuda Y; Kindai University, Nara Hospital, Nara, Japan., Bustos MA; Saint John's Health Center, Santa Monica, CA, United States., Winkowski D; Visiopharm A/S, Horsholm, Denmark, Denmark., Cho S; Department of Melanoma Medical Oncology, Melanoma Medical Oncology, MD Anderson Cancer Center, University of Texas, Houston, TX, United States., Basi A; Department of Melanoma Medical Oncology, Melanoma Medical Oncology, MD Anderson Cancer Center, University of Texas, Houston, TX, United States.; Department of Leukemia, MD Anderson Cancer Center, Houston, TX, United States., Baird R; Visiopharm A/S, Horsholm, Denmark, Denmark., Grimm EA; Department of Melanoma Medical Oncology, Melanoma Medical Oncology, MD Anderson Cancer Center, University of Texas, Houston, TX, United States., Davies MA; Department of Melanoma Medical Oncology, Melanoma Medical Oncology, MD Anderson Cancer Center, University of Texas, Houston, TX, United States., Hoon DSB; Saint John's Health Center, Santa Monica, CA, United States., Rao A; Department of Computational Medicine and Bioinformatics, University of Michigan, Ann Arbor, MI, United States.; Department of Biostatistics, University of Michigan, Ann Arbor, MI, United States.; Department of Biomedical Engineering, University of Michigan, Ann Arbor, MI, United States.; Department of Radiation Oncology, University of Michigan, Ann Arbor, MI, United States., Burks JK; Department of Melanoma Medical Oncology, Melanoma Medical Oncology, MD Anderson Cancer Center, University of Texas, Houston, TX, United States.; Department of Leukemia, MD Anderson Cancer Center, Houston, TX, United States., Ekmekcioglu S; Department of Melanoma Medical Oncology, Melanoma Medical Oncology, MD Anderson Cancer Center, University of Texas, Houston, TX, United States. |
| Source: | Frontiers in immunology [Front Immunol] 2025 Apr 29; Vol. 16, pp. 1560778. Date of Electronic Publication: 2025 Apr 29 (Print Publication: 2025). |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101560960 Publication Model: eCollection Cited Medium: Internet ISSN: 1664-3224 (Electronic) Linking ISSN: 16643224 NLM ISO Abbreviation: Front Immunol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| FullText | Links: – Type: pdflink Text: Availability: 1 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 40364843 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Characterizing spatial immune architecture in metastatic melanoma using high-dimensional multiplex imaging. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Eliason+J%22">Eliason J</searchLink>; Department of Computational Medicine and Bioinformatics, University of Michigan, Ann Arbor, MI, United States.<br /><searchLink fieldCode="AU" term="%22Krishnan+S%22">Krishnan S</searchLink>; Department of Computational Medicine and Bioinformatics, University of Michigan, Ann Arbor, MI, United States.<br /><searchLink fieldCode="AU" term="%22Fukuda+Y%22">Fukuda Y</searchLink>; Kindai University, Nara Hospital, Nara, Japan.<br /><searchLink fieldCode="AU" term="%22Bustos+MA%22">Bustos MA</searchLink>; Saint John's Health Center, Santa Monica, CA, United States.<br /><searchLink fieldCode="AU" term="%22Winkowski+D%22">Winkowski D</searchLink>; Visiopharm A/S, Horsholm, Denmark, Denmark.<br /><searchLink fieldCode="AU" term="%22Cho+S%22">Cho S</searchLink>; Department of Melanoma Medical Oncology, Melanoma Medical Oncology, MD Anderson Cancer Center, University of Texas, Houston, TX, United States.<br /><searchLink fieldCode="AU" term="%22Basi+A%22">Basi A</searchLink>; Department of Melanoma Medical Oncology, Melanoma Medical Oncology, MD Anderson Cancer Center, University of Texas, Houston, TX, United States.; Department of Leukemia, MD Anderson Cancer Center, Houston, TX, United States.<br /><searchLink fieldCode="AU" term="%22Baird+R%22">Baird R</searchLink>; Visiopharm A/S, Horsholm, Denmark, Denmark.<br /><searchLink fieldCode="AU" term="%22Grimm+EA%22">Grimm EA</searchLink>; Department of Melanoma Medical Oncology, Melanoma Medical Oncology, MD Anderson Cancer Center, University of Texas, Houston, TX, United States.<br /><searchLink fieldCode="AU" term="%22Davies+MA%22">Davies MA</searchLink>; Department of Melanoma Medical Oncology, Melanoma Medical Oncology, MD Anderson Cancer Center, University of Texas, Houston, TX, United States.<br /><searchLink fieldCode="AU" term="%22Hoon+DSB%22">Hoon DSB</searchLink>; Saint John's Health Center, Santa Monica, CA, United States.<br /><searchLink fieldCode="AU" term="%22Rao+A%22">Rao A</searchLink>; Department of Computational Medicine and Bioinformatics, University of Michigan, Ann Arbor, MI, United States.; Department of Biostatistics, University of Michigan, Ann Arbor, MI, United States.; Department of Biomedical Engineering, University of Michigan, Ann Arbor, MI, United States.; Department of Radiation Oncology, University of Michigan, Ann Arbor, MI, United States.<br /><searchLink fieldCode="AU" term="%22Burks+JK%22">Burks JK</searchLink>; Department of Melanoma Medical Oncology, Melanoma Medical Oncology, MD Anderson Cancer Center, University of Texas, Houston, TX, United States.; Department of Leukemia, MD Anderson Cancer Center, Houston, TX, United States.<br /><searchLink fieldCode="AU" term="%22Ekmekcioglu+S%22">Ekmekcioglu S</searchLink>; Department of Melanoma Medical Oncology, Melanoma Medical Oncology, MD Anderson Cancer Center, University of Texas, Houston, TX, United States. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22101560960%22">Frontiers in immunology</searchLink> [Front Immunol] 2025 Apr 29; Vol. 16, pp. 1560778. <i>Date of Electronic Publication: </i>2025 Apr 29 (<i>Print Publication: </i>2025). – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Frontiers+Research+Foundation]%22">Frontiers Research Foundation] </searchLink><i>Country of Publication: </i>Switzerland <i>NLM ID: </i>101560960 <i>Publication Model: </i>eCollection <i>Cited Medium: </i>Internet <i>ISSN: </i>1664-3224 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2216643224%22">16643224 </searchLink><i>NLM ISO Abbreviation: </i>Front Immunol <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=40364843 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.3389/fimmu.2025.1560778 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 1560778 Titles: – TitleFull: Characterizing spatial immune architecture in metastatic melanoma using high-dimensional multiplex imaging. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Eliason J – PersonEntity: Name: NameFull: Krishnan S – PersonEntity: Name: NameFull: Fukuda Y – PersonEntity: Name: NameFull: Bustos MA – PersonEntity: Name: NameFull: Winkowski D – PersonEntity: Name: NameFull: Cho S – PersonEntity: Name: NameFull: Basi A – PersonEntity: Name: NameFull: Baird R – PersonEntity: Name: NameFull: Grimm EA – PersonEntity: Name: NameFull: Davies MA – PersonEntity: Name: NameFull: Hoon DSB – PersonEntity: Name: NameFull: Rao A – PersonEntity: Name: NameFull: Burks JK – PersonEntity: Name: NameFull: Ekmekcioglu S IsPartOfRelationships: – BibEntity: Dates: – D: 29 M: 04 Text: 2025 Apr 29 Type: published Y: 2025 Identifiers: – Type: issn-electronic Value: 1664-3224 Numbering: – Type: volume Value: 16 Titles: – TitleFull: Frontiers in immunology Type: main |
| ResultId | 1 |